Navigation Links
Molecular marker could help spot pancreatic cancer early
Date:4/26/2010

CHAPEL HILL Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can be treated more successfully with surgery.

In a finding published April 26, 2010, in the online journal PLoS One, the researchers showed that a specific form of a protein called palladin is produced in large amounts in the "tumor nest," the cells that surround a pancreatic tumor.

By measuring the levels of this form of palladin in patient samples, doctors could have an improved way to screen for the deadly cancer, possibly catching it earlier than ever before, said senior study author Carol Otey, Ph.D., associate professor of cell and molecular physiology at UNC.

Otey is a member of the NC Translational and Clinical Sciences Institute (NC TRaCS), part of a collaborative effort of a national network of medical research institutions affiliated with the NIH Clinical and Translational Science Awards (CTSAs).

"The problem with pancreas cancer is it is almost never caught at an early stage," said Otey. "By the time a person develops suspicious symptoms, the disease has typically progressed too far. But if you can diagnose it early, it can be treated very effectively with surgery."

Palladin, a protein which Otey discovered a decade ago, plays an important role in cell motility, adhesion and structure. More recently, Otey and her collaborator Teri Brentnall at the University of Washington showed that palladin was mutated in an inherited form of pancreas cancer and was also produced in large amounts -- "upregulated" -- in a number of sporadic pancreas tumors.

Otey and her colleagues decided to see if this upregulation of palladin could provide a useful diagnostic tool for identifying the disease at earlier stages. They knew that the single palladin gene message can actually be cut and pas
'/>"/>

Contact: Les Lang
llang@unch.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Molecular discovery points to new therapies for brain tumors
2. USC researchers discover new molecular subtype of brain cancer
3. The Association for Molecular Pathology celebrates ruling in DNA patent case
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
6. Molecular pathways linked to sex, age affect outcomes in lung cancer
7. Ground Breaking Molecular Diagnostics Business Appoints New CEO
8. Select Topics in ALL: Molecular Characterization, Approaches to CNS Disease, and Post-remission Transplantation
9. Scientists show how molecular switch helps pancreatic cancer beat drugs
10. News from the Latest Issue of Molecular Medicine
11. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular marker could help spot pancreatic cancer early
(Date:4/18/2014)... (April 21, 2014) -- A group of scientists ... and the Sanders-Brown Center on Aging has found ... and neuropsychological function in Parkinson,s disease (PD). ... , the study, which assessed cognitive function in ... the dopamine replacement therapy commonly used to treat ...
(Date:4/18/2014)... The Gerontologist reports that among older Christians, ... in anxiety about death and increases in life satisfaction, ... particular, listening to gospel music is associated with a ... sense of control. , These associations are similar for ... both low- and high-socioeconomic status. , The article, titled ...
(Date:4/18/2014)... have been awarded two-year grants for their work on ... Of the 110 initial submissions to the new Novo ... four projects were funded, three of which are led ... Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., ... will use his $500,000 proof of principle grant to ...
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at Virginia ... blocking a particular molecule in metastatic breast cancer reduces ... of lung metastases. BRI scientists have found in models ... tumors by 60 - 80 percent and can keep ... The $1.8 million five-year grant comes from the National ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2
... Hopkins and elsewhere report what is believed to be ... inflammation of heart tissue and the subsequent damage leading ... latest findings from the Multiethnic Study of Atherosclerosis (MESA), ... the Journal of the American College of Cardiology, appear ...
... at Mattel Children,s Hospital UCLA have found that low-dose antidepressant ... adolescents suffering from irritable bowel syndrome, or IBS. ... students and 14 percent of high school kids in the ... the May issue of the peer-reviewed Journal of Pediatrics, is ...
... WASHINGTON, May 1 Speaker Nancy Pelosi today,released ... Information,Nondiscrimination Act, which the House passed this afternoon ... bill, which would prohibit health,insurance companies and employers ... test results, now goes to the President,s desk ...
... said today that there are more than 36,000 uninsured ... whom are on a waiting,list to receive health care ... a plan to help them gain access to health ... live with the,very real fear that a sudden illness ...
... Courage Center has received a,one-year grant of $150,000 ... to,support The Bridge to Independence. This coordinated campaign ... children with disabilities,through effective grassroots community organizing, policy ... leading member of the Minnesota Consortium of Citizens ...
... Shire plc (LSE: SHP, NASDAQ: SHPGY), the global ... present key scientific data on its Attention Deficit ... system and the investigational non-stimulant treatment under FDA ... Association (APA) annual meeting to be held May ...
Cached Medicine News:Health News:Study in 7,000 men and women ties obesity, inflammatory proteins to heart failure risk 2Health News:Study in 7,000 men and women ties obesity, inflammatory proteins to heart failure risk 3Health News:Antidepressant found to alleviate symptoms of irritable bowel syndrome in adolescents 2Health News:Pelosi: 'Genetic Information Nondiscrimination Act Will Protect Americans from Misuse of Genetic Information' 2Health News:Governor Rendell Says Passage of PA ABC Would Help More Than 36,000 Uninsured Citizens Living in the Lehigh Valley 2Health News:Governor Rendell Says Passage of PA ABC Would Help More Than 36,000 Uninsured Citizens Living in the Lehigh Valley 3Health News:Governor Rendell Says Passage of PA ABC Would Help More Than 36,000 Uninsured Citizens Living in the Lehigh Valley 4Health News:Governor Rendell Says Passage of PA ABC Would Help More Than 36,000 Uninsured Citizens Living in the Lehigh Valley 5Health News:Governor Rendell Says Passage of PA ABC Would Help More Than 36,000 Uninsured Citizens Living in the Lehigh Valley 6Health News:Courage Center Receives $150,000 Grant From Minneapolis Foundation 2Health News:Shire to present ADHD treatments scientific data at American Psychiatric Assoc. Meeting 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... wearable injector slightly larger than an Oreo cookie may soon ... drugs in the large doses required to treat a wide ... genetic disorders.  An emerging biologic drugs market ... analysts.   Many of these drugs will require a new type ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... 8, 2011 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... that they have initiated the first of two Phase ... VEGF Trap-Eye (aflibercept ophthalmic solution), an investigational new agent ... treatment of Diabetic Macular Edema (DME).  The companies are ...
... (NASDAQ: IDIX ), a biopharmaceutical company engaged in ... human viral diseases, today announced that it has commenced an ... All of these shares are being sold by Idenix. ... book-running manager and underwriter for the offering. Idenix intends to ...
Cached Medicine Technology:Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 2Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 3Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 4Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 5Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 6Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock 2
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Sera available in three levels for the control of accuracy and precision for up to 31 analytes...
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
Human based assayed sera available in three levels for the control of accuracy and precision for up to 25 analytes...
Medicine Products: